Telemos Capital (“Telemos”) announces that its portfolio company Sanoptis, an ophthalmology services group, has successfully secured financing from Barings Private Finance (“Barings”) and Deutsche Apotheker- und Ärztebank eG (“apoBank”). The senior facilities have been partially utilised as acquisition financing in the establishment of the Sanoptis group and will continue to be used to both support the company’s exciting buy-and-build strategy and provide operational flexibility.
The financing is reflective of the strength of Sanoptis’ proposition and ability to execute on the organic and inorganic growth opportunities within the European ophthalmology market, with four transactions already completed since establishment.
Nils Hagerstål and Dipesh Mahtani of Telemos, said: “We are delighted to have secured financing for Sanoptis, which reinforces the strength of the strategy and execution capabilities of the management team. Barings and apoBank have shown themselves to be ideal partners to flexibly support Sanoptis as it pursues its ambitious buy-and-build strategy.”
Dr. Volker Wendel, CEO of Sanoptis, commented: “Sanoptis has found excellent financing partners in Barings and apoBank and we look forward to executing our growth strategy with their support.”
Sebastian Lorenz of Barings, said: “Sanoptis is an innovative services group covering the full spectrum of ophthalmology treatments in a market with restricted supply. We are delighted to be working with Management and Telemos by providing tailored financing solutions and further supporting their buy-and-build strategy.”
